ALGS – aligos therapeutics, inc. - common stock (US:NASDAQ)

Sec Filings

Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Adage Capital Management, L.P.
Form 8-K Aligos Therapeutics, For: Feb 11
Form 8-K Aligos Therapeutics, For: Jan 30
Form EFFECT Aligos Therapeutics,
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com